Healthcare provider profile · identity verified

John Clarence Ehrmann, MD

General Practice · PENSACOLA, FL · NPI 1861691032

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	332	131
Amlodipine Besylate	Amlodipine Besylate	224	85
Lisinopril	Lisinopril	209	74
Rosuvastatin Calcium	Rosuvastatin Calcium	209	71
Losartan Potassium	Losartan Potassium	158	58
Levothyroxine Sodium	Levothyroxine Sodium	151	54
Gabapentin	Gabapentin	145	56
Omeprazole	Omeprazole	141	49
Metformin Hcl	Metformin Hcl	117	48
Albuterol Sulfate Hfa	Albuterol Sulfate	113	44
Pantoprazole Sodium	Pantoprazole Sodium	105	38
Hydrochlorothiazide	Hydrochlorothiazide	99	34
Furosemide	Furosemide	91	37
Potassium Chloride	Potassium Chloride	80	30
Trazodone Hcl	Trazodone Hcl	78	27
Duloxetine Hcl	Duloxetine Hcl	75	22
Tramadol Hcl	Tramadol Hcl	75	21
Alprazolam	Alprazolam	71	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	23
Fluticasone Propionate	Fluticasone Propionate	68	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	24
Metoprolol Succinate	Metoprolol Succinate	63	23
Tizanidine Hcl	Tizanidine Hcl	63	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	19
Baclofen	Baclofen	54	21
Buspirone Hcl	Buspirone Hcl	53	17
Carvedilol	Carvedilol	53	21
Tamsulosin Hcl	Tamsulosin Hcl	51	21
Clopidogrel	Clopidogrel Bisulfate	50	19
Lorazepam	Lorazepam	48	suppressed
Famotidine	Famotidine	45	23
Ozempic	Semaglutide	45	12
Montelukast Sodium	Montelukast Sodium	44	19
Oxycodone Hcl	Oxycodone Hcl	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	16
Alendronate Sodium	Alendronate Sodium	41	16
Eliquis	Apixaban	39	14
Zolpidem Tartrate	Zolpidem Tartrate	39	12
Amitriptyline Hcl	Amitriptyline Hcl	38	15
Metoprolol Tartrate	Metoprolol Tartrate	38	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	14
Prednisone	Prednisone	35	28
Meloxicam	Meloxicam	34	18
Sertraline Hcl	Sertraline Hcl	34	16
Trulicity	Dulaglutide	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	22
Spironolactone	Spironolactone	32	14
Triamcinolone Acetonide	Triamcinolone Acetonide	32	12
Bupropion Xl	Bupropion Hcl	29	suppressed
Promethazine Hcl	Promethazine Hcl	29	suppressed
Dexamethasone	Dexamethasone	27	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Ezetimibe	Ezetimibe	26	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	14
Sildenafil Citrate	Sildenafil Citrate	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	11
Clonidine Hcl	Clonidine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Celecoxib	Celecoxib	23	12
Cephalexin	Cephalexin	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Atenolol	Atenolol	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Finasteride	Finasteride	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	13
Mounjaro	Tirzepatide	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Ondansetron Odt	Ondansetron	19	11
Farxiga	Dapagliflozin Propanediol	18	11
Fenofibrate	Fenofibrate	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Fluconazole	Fluconazole	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Azithromycin	Azithromycin	13	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Naproxen	Naproxen	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Primidone	Primidone	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error